ATE135821T1 - Verfahren, das gemischte immunoglobuline verwendet, zum nachweis von rheumatischen faktoren - Google Patents
Verfahren, das gemischte immunoglobuline verwendet, zum nachweis von rheumatischen faktorenInfo
- Publication number
- ATE135821T1 ATE135821T1 AT90916889T AT90916889T ATE135821T1 AT E135821 T1 ATE135821 T1 AT E135821T1 AT 90916889 T AT90916889 T AT 90916889T AT 90916889 T AT90916889 T AT 90916889T AT E135821 T1 ATE135821 T1 AT E135821T1
- Authority
- AT
- Austria
- Prior art keywords
- detecting
- immunoglobulines
- mixed
- rheumatic factors
- factors
- Prior art date
Links
- 208000025747 Rheumatic disease Diseases 0.000 title 1
- 230000000552 rheumatic effect Effects 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- 239000012503 blood component Substances 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Joining Of Building Structures In Genera (AREA)
- Buildings Adapted To Withstand Abnormal External Influences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42547489A | 1989-10-23 | 1989-10-23 | |
| US51724690A | 1990-05-01 | 1990-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE135821T1 true ATE135821T1 (de) | 1996-04-15 |
Family
ID=27026697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90916889T ATE135821T1 (de) | 1989-10-23 | 1990-10-03 | Verfahren, das gemischte immunoglobuline verwendet, zum nachweis von rheumatischen faktoren |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0497886B1 (de) |
| JP (1) | JP2905595B2 (de) |
| AT (1) | ATE135821T1 (de) |
| CA (1) | CA2070411A1 (de) |
| DE (1) | DE69026106T2 (de) |
| DK (1) | DK0497886T3 (de) |
| ES (1) | ES2085917T3 (de) |
| WO (1) | WO1991005873A1 (de) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1484727A (fr) * | 1966-04-19 | 1967-06-16 | Réactif immunologique et son procédé d'obtention | |
| DE2930706A1 (de) * | 1979-07-28 | 1981-02-05 | Medac Klinische Spezialpraep | Verfahren zum nachweis von erregerspezifischen antikoerpern |
| US4361647A (en) * | 1980-05-22 | 1982-11-30 | Palo Alto Medical Research Foundation | Sandwich immunoassay and compositions for use therein |
| US4434227A (en) * | 1982-02-08 | 1984-02-28 | Abbott Laboratories | Immunoassay for class specific immunoglobulin antibodies |
| EP0323785A1 (de) * | 1987-12-28 | 1989-07-12 | The Regents Of The University Of California | Test für den IgvG-rheumatoiden Faktor |
-
1990
- 1990-10-03 EP EP90916889A patent/EP0497886B1/de not_active Expired - Lifetime
- 1990-10-03 DK DK90916889.0T patent/DK0497886T3/da active
- 1990-10-03 JP JP2515524A patent/JP2905595B2/ja not_active Expired - Lifetime
- 1990-10-03 ES ES90916889T patent/ES2085917T3/es not_active Expired - Lifetime
- 1990-10-03 AT AT90916889T patent/ATE135821T1/de not_active IP Right Cessation
- 1990-10-03 CA CA002070411A patent/CA2070411A1/en not_active Abandoned
- 1990-10-03 WO PCT/US1990/005624 patent/WO1991005873A1/en not_active Ceased
- 1990-10-03 DE DE69026106T patent/DE69026106T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05501919A (ja) | 1993-04-08 |
| JP2905595B2 (ja) | 1999-06-14 |
| CA2070411A1 (en) | 1991-04-24 |
| DE69026106T2 (de) | 1996-10-24 |
| DE69026106D1 (de) | 1996-04-25 |
| EP0497886A1 (de) | 1992-08-12 |
| ES2085917T3 (es) | 1996-06-16 |
| EP0497886A4 (en) | 1992-10-14 |
| WO1991005873A1 (en) | 1991-05-02 |
| DK0497886T3 (da) | 1996-06-24 |
| EP0497886B1 (de) | 1996-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE40602T1 (de) | Immunchemisches messverfahren. | |
| DE3788397D1 (de) | Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung. | |
| DE3484957D1 (de) | Verfahren zum nachweis von immunkomplexen im serum. | |
| ES515177A0 (es) | Procedimiento para el tratamiento de inmunoglobulina de suero. | |
| ATE15945T1 (de) | Verfahren zum nachweis von haemoglobin in faezes. | |
| DE3687884D1 (de) | Monoklonale antikoerper und verfahren zum nachweis von pilzpathogenen. | |
| ATE147167T1 (de) | Oxidative denaturierung von eiweissanalyten | |
| FI854395L (fi) | Sv40-expressionsvektor innehaollande hbxag-antigen som expressionsmarkering. | |
| ATE76512T1 (de) | Methode zum nachweis oder zur abschaetzung von biologischem material. | |
| NO843591L (no) | Fremgangsmaate for aa bestemme pivka-ii-innhold i blodplasma og middel for utfoerelse av denne | |
| DK0457804T3 (da) | M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop | |
| ES8505406A1 (es) | Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos | |
| DE68907620D1 (de) | Dichtungspruefverfahren von kunststoff-behaeltern. | |
| ATE1256T1 (de) | Diagnostisches mittel und verfahren zum nachweis von antimitochondrialen oder antinukleaeren antikoerpern. | |
| ATE55059T1 (de) | Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen. | |
| DE3587542D1 (de) | Verfahren zur Diagnose in vitro von menschlichen Cytomegalovirusinfektionen und Anwendung von monoklonalen Antikörpern gegen Cytomegaloviren, die mit einer cytomegalovirusinduzierten Proteinkinase reagieren. | |
| ATE135821T1 (de) | Verfahren, das gemischte immunoglobuline verwendet, zum nachweis von rheumatischen faktoren | |
| ATE137864T1 (de) | Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür | |
| PT86117A (fr) | Anticorps monoclonaux antigram (-), procede de preparation et applications | |
| FI844645A0 (fi) | 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar. | |
| DE3874741D1 (de) | Immunassay-verfahren. | |
| EP0556320A4 (en) | Monoclonal antibodies to hepatitis c virus and method for using same | |
| DE3767659D1 (de) | Verfahren und testelement zum auffinden von zellaesionen. | |
| EP0248147A3 (de) | Verfahren zur Bestimmung der Anwesenheit von Krebszellen | |
| KR900018678A (ko) | 엘라스타제-1의 면역 분석법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |